MEIP

Filed a patent for "combination therapies" on Mon, December 19, 2022

Filed a patent for "combination of a cdk inhibitor and a flt3 inhibitor for the treatment of cancer" on Thu, February 16, 2023

Filed a patent for "combination therapies" on Thu, June 1, 2023

Filed a patent for "combination therapies" on Thu, July 27, 2023

Filed a patent for "isoflavonoid compounds and methods for the treatment of cancer" on Thu, May 11, 2023

Filed a patent for "treatment of kras mutant cancers" on Thu, January 18, 2024

Filed a patent for "isoflavonoid compositions and methods for the treatment of cancer" on Thu, May 23, 2024

Filed a patent for "isoflavonoid compounds and methods for the treatment of cancer" on Thu, November 23, 2023

Filed a patent for "voruciclib dosing regimens and methods of treatment including the same" on Thu, June 20, 2024

Filed a patent for "combination therapy" on Thu, August 25, 2022

Filed a patent for "(alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases" on Thu, October 13, 2022

Filed a patent for "preparation of a 1,3,5-triazinyl benzimidazole" on Thu, April 27, 2023